乳腺浸润性微乳头状癌的多组学研究进展  

Overview of multi-omics research on invasive micropapillary carcinoma in breast

作　　者：闫晨名 蔡艺威 程立浩 范晓瑞 贾中明[1] 王晓红[1] Yan Chenming;Cai Yiwei;Cheng Lihao;Fan Xiaorui;Jia Zhongming;Wang Xiaohong(Department of Breast Surgery,Binzhou Medical University Hospital,Binzhou 256603,China)

机构地区：[1]滨州医学院附属医院乳腺外科,滨州256603

出　　处：《国际医药卫生导报》2024年第15期2465-2469,共5页International Medicine and Health Guidance News

基　　金：国家自然科学基金(81902702);山东省自然科学基金(ZR2017LH072);山东省医药卫生科技发展计划(202104010995)。

摘　　要：浸润性微乳头状癌是一种罕见的乳腺浸润性癌,由于其发病率较低,且通常与其他组织学类型(如浸润性导管癌)同时存在,极易漏诊。浸润性微乳头状癌具有较高的侵袭能力,严重影响患者的生活质量。随着多组学技术的进步,浸润性微乳头状癌的分子机制得到了进一步阐明,越来越多的潜在靶点已经被揭示。本文旨在综述浸润性微乳头状癌的多组学研究进展。Invasive micropapillary carcinoma is a rare type of invasive carcinoma of the breast that is highly susceptible to missed diagnosis due to its low incidence and its usual D0I:10.3760/45.2024.15.001 coexistence with other histologic types such as invasive ductal carcinoma.Invasive micropapillary carcinoma has high invasive capacity and severely affects the patients'quality of life.With the advancement of multi-omics technology,the molecular mechanism of invasive micropapillary carcinoma has been further elucidated,and more and more potential targets have been revealed.The aim of this article is to review the progress of multi-omics research on invasive micropapillary carcinoma.

关 键 词：浸润性微乳头状癌 多组学 分子机制 进展 

分 类 号：R737.9[医药卫生—肿瘤]